bf/NYSE:CPNG_icon.jpeg

COM:COUPANG

Coupang

  • Stock

USD

Last Close

24.00

22/11 21:00

Market Cap

38.21B

Beta: -

Volume Today

11.79M

Avg: -

Company Overview

Metric
Company NameCoupang, Inc.한국투자신탁운용
SymbolCPNG
MSH IDCOM:COUPANGCOM:KOREAINVESTMENT:KIM
MarketSTOCKSPRIVATE
SectorConsumer CyclicalFinancial Services & Finance
IndustrySpecialty RetailInvestment Management
CountryKRKR
StageEquity
Employee Count78K
Websitecoupang.comkim.koreainvestment.com
LinkedIn
Founders

Market Metrics

Metric
Market Cap38.21B
Enterprise Value
Monthly Web Traffic28.64K
Web Traffic Growth-0.18
Valuation
Raised Capital

Financial Performance

Metric
Revenue24.38B
Revenue (LTM)
Revenue (NTM)
Gross Profit6.19B
EBITDA1.09B
Operating Income473M
Net Income1.36B
EPS0.75
Diluted EPS0.75
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Growth Metrics

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Profitability Ratios

Metric
Gross Profit Margin0.27
Operating Profit Margin0.02
EBITDA Margin0.04
Net Profit Margin0.06
Return on Equity0.44
Return on Assets0.10
Return on Capital Employed0.07

Valuation Multiples

Metric
P/E Ratio57.41
P/B Ratio8.42
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio1.99
EV Multiple85.48

Operational Metrics

Metric
Days Sales Outstanding4.50
Days Payables Outstanding97.05
Days Inventory Outstanding37.23
Operating Cycle48.31
Cash Conversion Cycle-54.86
Asset Turnover1.79

Cash Flow Metrics

Metric
Operating Cash Flow2.65B
Free Cash Flow1.76B
Cash Flow to Debt1.87
Operating Cash Flow/Sales0.12
Free Cash Flow Yield0.07

Balance Sheet Metrics

Metric
Cash & Equivalents5.60B
Accounts Receivable-133M
Inventory1.67B
Goodwill
Debt to Capitalization0.45
Debt to Assets0.24
Current Ratio1.14
Quick Ratio0.89

Efficiency Metrics

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue0.01
R&D to Revenue
SG&A to Revenue0.23